Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Public ClinicalTrials.gov record NCT01536015. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose is to demonstrate superiority of Rotigotine over Placebo on motor symptoms when used in subjects with symptoms of Gastrointestinal Dysfunction. Hypothesis: Rotigotine will decrease OFF time compared to Placebo.
Study identification
- NCT ID
- NCT01536015
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 2012 (Type not available)
- Primary completion
- Oct 2013 (Actual)
- Completion
- Oct 2013 (Actual)
- Last update posted
- Aug 1, 2014
2012 – 2013
United States locations
- U.S. sites
- 26
- U.S. states
- 15
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 011 | Birmingham | Alabama | — | — |
| 001 | Gilbert | Arizona | — | — |
| 022 | Fountain Valley | California | — | — |
| 017 | Irvine | California | — | — |
| 028 | Pasadena | California | — | — |
| 015 | Sunnyvale | California | — | — |
| 008 | Gainesville | Florida | — | — |
| 009 | Miami | Florida | — | — |
| 010 | Ormond Beach | Florida | — | — |
| 006 | Sunrise | Florida | — | — |
| 032 | Annapolis | Maryland | — | — |
| 027 | Lincoln | Nebraska | — | — |
| 016 | Commack | New York | — | — |
| 026 | Mineola | New York | — | — |
| 034 | Charlotte | North Carolina | — | — |
| 002 | Raleigh | North Carolina | — | — |
| 007 | Salisbury | North Carolina | — | — |
| 021 | Toledo | Ohio | — | — |
| 023 | Tulsa | Oklahoma | — | — |
| 031 | Cordova | Tennessee | — | — |
| 018 | Memphis | Tennessee | — | — |
| 014 | Houston | Texas | — | — |
| 030 | Richmond | Virginia | — | — |
| 003 | Virginia Beach | Virginia | — | — |
| 012 | Kirkland | Washington | — | — |
| 013 | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01536015, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 1, 2014 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01536015 live on ClinicalTrials.gov.